Top 25 Paratek Pharmaceuticals investors
The most complete profiles first. Showing 25 of 25.
Annie MitsakVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Sunny ReddyVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Aftab KheraniVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Alexander WongVerified
Private Equity Firm · United States
Health CareTelecommunicationsE-commerceEnterprise SoftwarePortfolio: WX Brands, DotBlu, Emotive Communications, Aurora Parts & Accessories and 28 more
Verified email available
Andrew SchiffVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more
Verified email available
AnneVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Eric AguiarVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Josh BilenkerVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Paulina HillVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Robert WenzelVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Francesco Draetta
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Katie Kerfoot
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Michelle Doig
Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Scott Braunstein
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
Sophie Phillips
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Paratek Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 25 Paratek Pharmaceuticals investors. 14 of them (56%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (23), Private Equity Firms (13) and Advisor Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Paratek Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Series B (6) and Seed (5).
Where are Paratek Pharmaceuticals investors based?
Most are based in the United States (19), the United Kingdom (5) and Canada (1).
Which companies have Paratek Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Spruce Biosciences (24), Cytos (18), Reneo Pharmaceuticals (18), Verona Pharma (18) and GTx (18).
How do I contact Paratek Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.